US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Alkermes PLC

49.21

+0.34000.70%

Post-market: 49.210.00000.00%19:54 EDT

Volume:1.13M

Turnover:55.48M

Market Cap:8.26B

PE:126.75

High:49.58

Open:48.94

Low:48.87

Close:48.87

52wk High:55.67

52wk Low:25.17

Shares:167.76M

Float Shares:155.00M

Volume Ratio:0.88

T/O Rate:0.73%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.3882

EPS(LYR):1.43

ROE:3.85%

ROA:4.20%

PB:4.56

PE(LYR):34.41

Loading ...

Overview Company News Filings

Alkermes presents real-world study comparing Lybalvi versus olanzapine adherence, relapse proxies

Alkermes shareholders approve 2018 stock plan share increase by 5.9 million

Alkermes Advances Phase 3 Narcolepsy Study With ALKS 2680, Adding a New Catalyst to Its Pipeline

Alkermes Is Maintained at Outperform by Baird

Sector Update: Healthcare Stocks Advance Late Afternoon

MT Newswires Live

Alkermes' (NASDAQ:ALKS) Conservative Accounting Might Explain Soft Earnings

Simply Wall St.

Stock Track | Alkermes Soars 6.37% Intraday on Positive Phase 3 Trial Results for Lumryz in Idiopathic Hypersomnia

Alkermes Phase 3 Trial Meets Primary Endpoint for Hypersomnia Treatment

MT Newswires Live

Analysts Conflicted on These Healthcare Names: Cronos Group (CRON), Savara (SVRA) and Alkermes (ALKS)

BRIEF-Alkermes Announces Positive Topline Results From Revitalyz Phase 3 Study Evaluating Lumryz

Alkermes says Phase 3 REVITALYZ trial shows LUMRYZ improves idiopathic hypersomnia sleepiness

Alkermes Plc - May Not Market Lumryz for Ih Before March 1, 2028

THOMSON REUTERS

Alkermes Plc - Lumryz Meets All Primary and Key Secondary Endpoints in Revitalyz Phase 3 Study

THOMSON REUTERS

Alkermes Plc - Lumryz Safety Profile in Revitalyz Study Consistent With Known Safety Data

THOMSON REUTERS

Alkermes Announces Positive Topline Results From Revitalyz℠ Phase 3 Study Evaluating Lumryz® (Sodium Oxybate) Extended-Release in Adults With Idiopathic Hypersomnia

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY), Maravai Lifesciences Holdings (MRVI) and Alkermes (ALKS)

Analysts Offer Insights on Healthcare Companies: Medline (MDLN), Aclaris Therapeutics (ACRS) and Alkermes (ALKS)

Alkermes price target raised to $50 from $45 at Needham

Alkermes Analysts Increase Their Forecasts Following Strong Q1 Results

Benzinga Earnings

Alkermes' Q1 Revenue Beat Highlights 'Underappreciated' Core Business, RBC Says

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/ALKS/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALKS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALKS\",,,,,undefined,":{"symbol":"ALKS","market":"US","secType":"STK","nameCN":"Alkermes PLC","latestPrice":49.21,"timestamp":1787688000000,"preClose":48.87,"halted":0,"volume":1127442,"hourTrading":{"tag":"盘后","latestPrice":49.21,"preClose":49.21,"latestTime":"19:54 EDT","volume":251809,"amount":12391454.39,"timestamp":1787702045907,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0069572334765705636,"floatShares":155000000,"shares":167763272,"eps":0.388236,"marketStatus":"Not Yet Opened","change":0.34,"latestTime":"08-25 16:00:00 EDT","open":48.935,"high":49.58,"low":48.87,"amount":55477226.735759996,"amplitude":0.014528,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.388236,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787731200000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":48.87,"preHourTrading":{"tag":"盘前","latestPrice":49.49,"preClose":48.87,"latestTime":"09:27 EDT","volume":1473,"amount":72309.857235,"timestamp":1787664470037,"change":0.62,"changeRate":0.012687,"amplitude":0.012073},"postHourTrading":{"tag":"盘后","latestPrice":49.21,"preClose":49.21,"latestTime":"19:54 EDT","volume":251809,"amount":12391454.39,"timestamp":1787702045907,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.882655,"impliedVol":0.391,"impliedVolPercentile":0.1275},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALKS\",,,,,undefined,":{"symbol":"ALKS","floatShares":155000000,"roa":"4.20%","roe":"3.85%","lyrEps":1.43,"volumeRatio":0.882655,"shares":167763272,"dividePrice":0,"high":49.58,"amplitude":0.014528,"preClose":48.87,"low":48.87,"week52Low":25.165,"pbRate":"4.56","psRate":"4.95","week52High":55.67,"institutionHeld":0.9671,"latestPrice":49.21,"eps":0.388236,"divideRate":0,"volume":1127442,"delay":0,"ttmEps":0.388236,"open":48.935,"prevYearClose":27.98,"prevWeekClose":48.33,"prevMonthClose":48.99,"prevQuarterClose":52.395,"fiveDayClose":49.48,"twentyDayClose":50.5,"sixtyDayClose":42.19,"dividendPayoutRate":0,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALKS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-28","symbol":"ALKS","fiscalQuarterEnding":"2026/06","expectedEps":-0.04,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785211200000,"reportTimeType":"pre","actualEps":0},{"market":"US","date":"2026-05-05","symbol":"ALKS","fiscalQuarterEnding":"2026/03","expectedEps":-0.57,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"pre","actualEps":-0.4},{"market":"US","date":"2026-02-25","symbol":"ALKS","fiscalQuarterEnding":"2025/12","expectedEps":0.31,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1771995600000,"reportTimeType":"pre","actualEps":0.34},{"market":"US","date":"2026-01-12","symbol":"ALKS","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1768194000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-10-28","symbol":"ALKS","fiscalQuarterEnding":"2025/09","expectedEps":0.34,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1761624000000,"reportTimeType":"pre","actualEps":0.49}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALKS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALKS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2105,"buy":0.5263,"hold":0.2105,"sell":0.0526,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5263,"analysts":19,"updateTime":1784606400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALKS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALKS","date":"2026-08-24","current":126.7528,"percent":0.986356,"low":-99.853332,"twenty":-40.804002,"median":13.319617,"eighty":18.760477,"high":128.125542,"avg":-5.455943,"sd":41.685763,"marketCap":8107998935},"quantilePoints":[{"date":"2021-08-27","current":-79.882598,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":5019023649},{"date":"2021-09-03","current":-76.672915,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":4817359246},{"date":"2021-09-10","current":-78.367628,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":4923838051},{"date":"2021-09-17","current":-77.314852,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":4857692127},{"date":"2021-09-24","current":-82.373313,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":5175515225},{"date":"2021-10-01","current":-79.292017,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":4981917399},{"date":"2021-10-08","current":-81.397569,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":5114209247},{"date":"2021-10-15","current":-81.320536,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":5109369301},{"date":"2021-10-22","current":-79.214984,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":4977077453},{"date":"2021-10-29","current":-53.423232,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":4898055566},{"date":"2021-11-05","current":-53.493781,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":4904523781},{"date":"2021-11-12","current":-42.294127,"twenty":-50.154251,"median":-35.906358,"eighty":-20.409777,"marketCap":3877694700},{"date":"2021-11-19","current":-40.98897,"twenty":-49.694628,"median":-35.906358,"eighty":-20.409777,"marketCap":3758032729},{"date":"2021-11-26","current":-39.630902,"twenty":-49.492729,"median":-35.906358,"eighty":-20.409777,"marketCap":3633519596},{"date":"2021-12-03","current":-38.8725,"twenty":-49.409499,"median":-35.906358,"eighty":-20.409777,"marketCap":3563986288},{"date":"2021-12-10","current":-38.502118,"twenty":-49.260842,"median":-35.906358,"eighty":-20.409777,"marketCap":3530028161},{"date":"2021-12-17","current":-41.200617,"twenty":-48.983435,"median":-35.906358,"eighty":-20.409777,"marketCap":3777437373},{"date":"2021-12-23","current":-42.488136,"twenty":-48.911898,"median":-35.906358,"eighty":-20.409777,"marketCap":3895482291},{"date":"2021-12-31","current":-41.024245,"twenty":-48.71686,"median":-35.906358,"eighty":-20.409777,"marketCap":3761266836},{"date":"2022-01-07","current":-42.347038,"twenty":-48.396814,"median":-35.934227,"eighty":-20.409786,"marketCap":3882545861},{"date":"2022-01-14","current":-44.534057,"twenty":-48.237657,"median":-35.934227,"eighty":-20.409786,"marketCap":4083060516},{"date":"2022-01-21","current":-42.329401,"twenty":-48.134628,"median":-35.934227,"eighty":-20.409786,"marketCap":3880928808},{"date":"2022-01-28","current":-44.234224,"twenty":-47.856145,"median":-35.934227,"eighty":-20.409786,"marketCap":4055570604},{"date":"2022-02-04","current":-41.817921,"twenty":-47.644696,"median":-35.934227,"eighty":-20.409786,"marketCap":3834034251},{"date":"2022-02-11","current":-40.918421,"twenty":-47.524593,"median":-35.934227,"eighty":-20.409786,"marketCap":3751564514},{"date":"2022-02-18","current":-84.332018,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":4062188990},{"date":"2022-02-25","current":-83.424138,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":4018457290},{"date":"2022-03-04","current":-77.943229,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":3754447400},{"date":"2022-03-11","current":-81.978254,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":3948810510},{"date":"2022-03-18","current":-87.82904,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":4230637018},{"date":"2022-03-25","current":-92.233942,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":4442816746},{"date":"2022-04-01","current":-94.35233,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":4544857379},{"date":"2022-04-08","current":-99.631487,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":4799149114},{"date":"2022-04-14","current":-98.723607,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":4755417414},{"date":"2022-04-22","current":-95.615075,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":4605682543},{"date":"2022-04-29","current":-76.473016,"twenty":-47.524593,"median":-36.079146,"eighty":-20.409786,"marketCap":4714867305},{"date":"2022-05-06","current":-73.239148,"twenty":-47.644696,"median":-36.311039,"eighty":-20.409786,"marketCap":4515486435},{"date":"2022-05-13","current":-71.251115,"twenty":-47.856145,"median":-36.514549,"eighty":-20.409786,"marketCap":4392916227},{"date":"2022-05-20","current":-79.521333,"twenty":-48.134628,"median":-36.669968,"eighty":-20.409786,"marketCap":4902808290},{"date":"2022-05-27","current":-80.952717,"twenty":-48.282786,"median":-36.809313,"eighty":-20.409786,"marketCap":4991058839},{"date":"2022-06-03","current":-77.692343,"twenty":-48.396814,"median":-36.895372,"eighty":-20.409786,"marketCap":4790043699},{"date":"2022-06-10","current":-73.104657,"twenty":-48.753891,"median":-37.077955,"eighty":-20.409786,"marketCap":4507194550},{"date":"2022-06-17","current":-74.622125,"twenty":-48.950091,"median":-37.212055,"eighty":-20.409786,"marketCap":4600752485},{"date":"2022-06-24","current":-79.09466,"twenty":-49.022902,"median":-37.321505,"eighty":-20.409777,"marketCap":4876502188},{"date":"2022-07-01","current":-81.277684,"twenty":-49.282838,"median":-37.389331,"eighty":-20.409777,"marketCap":5011094305},{"date":"2022-07-08","current":-84.791819,"twenty":-49.409499,"median":-37.46584,"eighty":-20.409777,"marketCap":5227754786},{"date":"2022-07-15","current":-79.68035,"twenty":-49.492729,"median":-37.601025,"eighty":-20.409777,"marketCap":4912612269},{"date":"2022-07-22","current":-76.725281,"twenty":-49.769136,"median":-37.711507,"eighty":-20.409777,"marketCap":4730420500},{"date":"2022-07-29","current":-44.659913,"twenty":-50.043112,"median":-37.815476,"eighty":-20.409777,"marketCap":4204909440},{"date":"2022-08-05","current":-44.956483,"twenty":-50.043112,"median":-37.914647,"eighty":-20.409777,"marketCap":4232832666},{"date":"2022-08-12","current":-45.619403,"twenty":-50.043112,"median":-38.002104,"eighty":-20.409777,"marketCap":4295249291},{"date":"2022-08-19","current":-44.066773,"twenty":-50.043112,"median":-38.10506,"eighty":-20.409777,"marketCap":4149062986},{"date":"2022-08-26","current":-42.810713,"twenty":-50.043112,"median":-38.291941,"eighty":-20.409777,"marketCap":4030799908},{"date":"2022-09-02","current":-42.758378,"twenty":-50.043112,"median":-38.448007,"eighty":-20.409777,"marketCap":4025872280},{"date":"2022-09-09","current":-41.886114,"twenty":-50.043112,"median":-38.5362,"eighty":-20.409777,"marketCap":3943745142},{"date":"2022-09-16","current":-40.769616,"twenty":-50.043112,"median":-38.660853,"eighty":-20.409777,"marketCap":3838622406},{"date":"2022-09-23","current":-38.937862,"twenty":-50.043112,"median":-38.765906,"eighty":-20.409777,"marketCap":3666155418},{"date":"2022-09-30","current":-38.955307,"twenty":-50.043112,"median":-38.937862,"eighty":-20.409777,"marketCap":3667797960},{"date":"2022-10-07","current":-38.606401,"twenty":-50.043112,"median":-39.109838,"eighty":-20.409777,"marketCap":3634947105},{"date":"2022-10-14","current":-39.46122,"twenty":-50.043112,"median":-39.133049,"eighty":-20.409777,"marketCap":3715431700},{"date":"2022-10-21","current":-38.83319,"twenty":-50.043112,"median":-39.135862,"eighty":-20.409777,"marketCap":3656300161},{"date":"2022-10-28","current":-40.699835,"twenty":-50.043112,"median":-39.199541,"eighty":-20.409777,"marketCap":3832052235},{"date":"2022-11-04","current":-30.511153,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":3940210296},{"date":"2022-11-11","current":-30.014933,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":3876128478},{"date":"2022-11-18","current":-29.824079,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":3851481624},{"date":"2022-11-25","current":-30.791072,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":3976359015},{"date":"2022-12-02","current":-33.195829,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":4286909368},{"date":"2022-12-09","current":-31.427251,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":4058515193},{"date":"2022-12-16","current":-32.470585,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":4193251325},{"date":"2022-12-23","current":-32.432414,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":4188321954},{"date":"2022-12-30","current":-33.246723,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":4293481862},{"date":"2023-01-06","current":-34.493635,"twenty":-49.769136,"median":-39.154696,"eighty":-20.409777,"marketCap":4454507971},{"date":"2023-01-13","current":-34.748106,"twenty":-49.492729,"median":-39.12976,"eighty":-20.409777,"marketCap":4487370442},{"date":"2023-01-20","current":-35.269773,"twenty":-49.420616,"median":-39.023312,"eighty":-20.409777,"marketCap":4554738508},{"date":"2023-01-27","current":-36.923839,"twenty":-49.282838,"median":-38.850635,"eighty":-20.409777,"marketCap":4768344571},{"date":"2023-02-03","current":-34.799001,"twenty":-48.983435,"median":-38.742102,"eighty":-20.409777,"marketCap":4493942936},{"date":"2023-02-10","current":-34.468187,"twenty":-48.9133,"median":-38.606401,"eighty":-20.409777,"marketCap":4451221724},{"date":"2023-02-17","current":-29.155811,"twenty":-48.645431,"median":-38.5362,"eighty":-20.409777,"marketCap":4614402682},{"date":"2023-02-24","current":-28.231383,"twenty":-48.351507,"median":-38.448007,"eighty":-20.409777,"marketCap":4468096363},{"date":"2023-03-03","current":-28.304091,"twenty":-48.220837,"median":-38.373879,"eighty":-20.409777,"marketCap":4479603601},{"date":"2023-03-10","current":-27.639335,"twenty":-48.116754,"median":-38.274941,"eighty":-20.409777,"marketCap":4374394563},{"date":"2023-03-17","current":-27.036899,"twenty":-47.811464,"median":-38.093155,"eighty":-20.409777,"marketCap":4279048871},{"date":"2023-03-24","current":-27.514693,"twenty":-47.598057,"median":-37.993052,"eighty":-20.409777,"marketCap":4354667868},{"date":"2023-03-31","current":-29.280453,"twenty":-47.463781,"median":-37.913785,"eighty":-20.409786,"marketCap":4634129377},{"date":"2023-04-06","current":-30.506098,"twenty":-47.463781,"median":-37.82284,"eighty":-20.409786,"marketCap":4828108542},{"date":"2023-04-14","current":-31.035826,"twenty":-47.475869,"median":-37.711507,"eighty":-20.409777,"marketCap":4911946995},{"date":"2023-04-21","current":-30.121785,"twenty":-47.475869,"median":-37.601025,"eighty":-20.409777,"marketCap":4767284567},{"date":"2023-04-28","current":-28.670049,"twenty":-47.475869,"median":-37.46584,"eighty":-20.409777,"marketCap":4707880022},{"date":"2023-05-05","current":-29.044358,"twenty":-47.475869,"median":-37.38821,"eighty":-20.409777,"marketCap":4769344934},{"date":"2023-05-12","current":-31.543123,"twenty":-47.378573,"median":-37.313027,"eighty":-20.409777,"marketCap":5179664753},{"date":"2023-05-19","current":-30.531477,"twenty":-47.214893,"median":-37.152993,"eighty":-20.409777,"marketCap":5013543369},{"date":"2023-05-26","current":-29.722161,"twenty":-47.214893,"median":-36.987674,"eighty":-20.409777,"marketCap":4880646261},{"date":"2023-06-02","current":-29.620996,"twenty":-47.130816,"median":-36.919193,"eighty":-20.409767,"marketCap":4864034123},{"date":"2023-06-09","current":-31.907316,"twenty":-46.901522,"median":-36.809313,"eighty":-20.409767,"marketCap":5239468451},{"date":"2023-06-16","current":-32.301858,"twenty":-46.574329,"median":-36.669968,"eighty":-20.409767,"marketCap":5304255791},{"date":"2023-06-23","current":-34.021656,"twenty":-46.462045,"median":-36.564066,"eighty":-20.409758,"marketCap":5586662143},{"date":"2023-06-30","current":-31.69487,"twenty":-46.464564,"median":-36.443843,"eighty":-20.409749,"marketCap":5204582960},{"date":"2023-07-07","current":-30.399963,"twenty":-46.464564,"median":-36.324905,"eighty":-20.409749,"marketCap":4991947589},{"date":"2023-07-14","current":-30.359498,"twenty":-46.464564,"median":-36.212917,"eighty":-20.409749,"marketCap":4985302733},{"date":"2023-07-21","current":-32.342324,"twenty":-46.464564,"median":-35.934227,"eighty":-20.409749,"marketCap":5310900646},{"date":"2023-07-28","current":48.950981,"twenty":-46.442933,"median":-35.452039,"eighty":-20.368741,"marketCap":5041559440},{"date":"2023-08-04","current":44.683255,"twenty":-46.317214,"median":-35.211157,"eighty":-20.301088,"marketCap":4602017848},{"date":"2023-08-11","current":44.87732,"twenty":-45.967039,"median":-35.023652,"eighty":-20.120159,"marketCap":4622004896},{"date":"2023-08-18","current":46.446004,"twenty":-45.664437,"median":-34.69182,"eighty":-19.956848,"marketCap":4783566869},{"date":"2023-08-25","current":44.570051,"twenty":-45.404618,"median":-34.474549,"eighty":-19.830023,"marketCap":4590358736},{"date":"2023-09-01","current":47.206089,"twenty":-44.974989,"median":-34.130848,"eighty":-19.651548,"marketCap":4861849474},{"date":"2023-09-08","current":47.206089,"twenty":-44.907093,"median":-33.585511,"eighty":-19.51296,"marketCap":4861849474},{"date":"2023-09-15","current":48.273441,"twenty":-44.907093,"median":-33.253085,"eighty":-19.271435,"marketCap":4971778239},{"date":"2023-09-22","current":48.047033,"twenty":-44.802128,"median":-33.04036,"eighty":-19.191423,"marketCap":4948460016},{"date":"2023-09-29","current":45.540372,"twenty":-44.659913,"median":-32.766368,"eighty":-19.065691,"marketCap":4690293977},{"date":"2023-10-06","current":45.993188,"twenty":-44.528541,"median":-32.483308,"eighty":-18.951388,"marketCap":4736930423},{"date":"2023-10-13","current":44.262783,"twenty":-44.236515,"median":-32.381007,"eighty":-18.699922,"marketCap":4558712576},{"date":"2023-10-20","current":43.357151,"twenty":-44.110763,"median":-32.257067,"eighty":-18.558361,"marketCap":4465439685},{"date":"2023-10-27","current":19.196586,"twenty":-44.052817,"median":-32.165219,"eighty":-18.485448,"marketCap":4121967764},{"date":"2023-11-03","current":19.080008,"twenty":-43.835622,"median":-32.114324,"eighty":-18.329394,"marketCap":4096935571},{"date":"2023-11-10","current":19.04892,"twenty":-43.835622,"median":-31.907316,"eighty":-18.128571,"marketCap":4090260319},{"date":"2023-11-17","current":18.162924,"twenty":-43.835622,"median":-31.735336,"eighty":-17.870084,"marketCap":3900015653},{"date":"2023-11-24","current":18.955657,"twenty":-43.835622,"median":-31.583589,"eighty":-17.644018,"marketCap":4070234565},{"date":"2023-12-01","current":18.76136,"twenty":-43.835622,"median":-31.427251,"eighty":-17.293018,"marketCap":4028514244},{"date":"2023-12-08","current":20.331283,"twenty":-43.821513,"median":-31.320561,"eighty":-17.111515,"marketCap":4365614441},{"date":"2023-12-15","current":20.945263,"twenty":-43.821513,"median":-30.985981,"eighty":-16.974211,"marketCap":4497450657},{"date":"2023-12-22","current":21.411577,"twenty":-43.821513,"median":-30.840029,"eighty":-16.775651,"marketCap":4597579429},{"date":"2023-12-29","current":21.668049,"twenty":-43.835622,"median":-30.75404,"eighty":-16.674022,"marketCap":4652650253},{"date":"2024-01-05","current":22.250942,"twenty":-43.849732,"median":-30.587118,"eighty":-16.545483,"marketCap":4777811218},{"date":"2024-01-12","current":21.714681,"twenty":-43.849732,"median":-30.537472,"eighty":-16.468673,"marketCap":4662663130},{"date":"2024-01-19","current":21.574787,"twenty":-43.863842,"median":-30.498429,"eighty":-16.419138,"marketCap":4632624499},{"date":"2024-01-26","current":21.776856,"twenty":-43.849732,"median":-30.390709,"eighty":-16.359531,"marketCap":4676013633},{"date":"2024-02-02","current":20.937491,"twenty":-43.849732,"median":-30.268366,"eighty":-16.245798,"marketCap":4495781844},{"date":"2024-02-09","current":20.805369,"twenty":-43.849732,"median":-30.124302,"eighty":-16.099824,"marketCap":4467412026},{"date":"2024-02-16","current":15.282535,"twenty":-43.849732,"median":-30.000061,"eighty":-15.989003,"marketCap":5436868800},{"date":"2024-02-23","current":13.569352,"twenty":-43.849732,"median":-29.813586,"eighty":-15.868185,"marketCap":4827391800},{"date":"2024-03-01","current":13.943479,"twenty":-43.835622,"median":-29.691811,"eighty":-15.810302,"marketCap":4960490388},{"date":"2024-03-08","current":13.830767,"twenty":-43.835622,"median":-29.445673,"eighty":-15.761184,"marketCap":4920392116},{"date":"2024-03-15","current":13.563075,"twenty":-43.835622,"median":-29.155811,"eighty":-15.689068,"marketCap":4825158721},{"date":"2024-03-22","current":12.666071,"twenty":-43.835622,"median":-28.997047,"eighty":-15.65825,"marketCap":4506043307},{"date":"2024-03-28","current":12.797569,"twenty":-43.835622,"median":-28.957305,"eighty":-15.60417,"marketCap":4552824624},{"date":"2024-04-05","current":12.121293,"twenty":-43.849732,"median":-28.827848,"eighty":-15.449766,"marketCap":4312234992},{"date":"2024-04-12","current":11.884271,"twenty":-43.849732,"median":-28.713822,"eighty":-15.310254,"marketCap":4227912733},{"date":"2024-04-19","current":11.299331,"twenty":-43.849732,"median":-28.508069,"eighty":-15.24785,"marketCap":4019816188},{"date":"2024-04-26","current":11.622713,"twenty":-43.835622,"median":-28.43912,"eighty":-15.200526,"marketCap":4134861432},{"date":"2024-05-03","current":9.294065,"twenty":-43.835622,"median":-28.43912,"eighty":-15.01869,"marketCap":4037620480},{"date":"2024-05-10","current":9.449875,"twenty":-43.835622,"median":-28.43912,"eighty":-14.970096,"marketCap":4105309004},{"date":"2024-05-17","current":9.52778,"twenty":-43.835622,"median":-28.43912,"eighty":-14.582911,"marketCap":4139153267},{"date":"2024-05-24","current":9.348598,"twenty":-43.835622,"median":-28.43912,"eighty":-14.167324,"marketCap":4061311464},{"date":"2024-05-31","current":9.114883,"twenty":-43.835622,"median":-28.43912,"eighty":-13.940216,"marketCap":3959778677},{"date":"2024-06-07","current":9.313541,"twenty":-43.835622,"median":-28.43912,"eighty":-13.607896,"marketCap":4046081546},{"date":"2024-06-14","current":9.543361,"twenty":-43.835622,"median":-28.43912,"eighty":-13.123801,"marketCap":4145922119},{"date":"2024-06-21","current":9.718647,"twenty":-43.849732,"median":-28.439666,"eighty":-12.956146,"marketCap":4222071709},{"date":"2024-06-28","current":9.387551,"twenty":-43.849732,"median":-28.439666,"eighty":-12.533786,"marketCap":4078233595},{"date":"2024-07-05","current":9.46156,"twenty":-43.849732,"median":-28.439666,"eighty":-12.248451,"marketCap":4110385644},{"date":"2024-07-12","current":9.181102,"twenty":-43.849732,"median":-28.439666,"eighty":-11.555991,"marketCap":3988546300},{"date":"2024-07-19","current":9.671904,"twenty":-43.849732,"median":-28.439666,"eighty":-11.295982,"marketCap":4201765152},{"date":"2024-07-26","current":15.900891,"twenty":-43.849732,"median":-28.439666,"eighty":-10.747072,"marketCap":4590953012},{"date":"2024-08-02","current":15.809638,"twenty":-43.849732,"median":-28.439666,"eighty":9.065803,"marketCap":4564606079},{"date":"2024-08-09","current":14.868588,"twenty":-43.849732,"median":-28.439666,"eighty":9.206032,"marketCap":4292903337},{"date":"2024-08-16","current":15.541581,"twenty":-43.849732,"median":-28.439666,"eighty":9.350072,"marketCap":4487211965},{"date":"2024-08-23","current":15.940815,"twenty":-43.849732,"median":-28.439666,"eighty":9.384045,"marketCap":4602479795},{"date":"2024-08-30","current":16.225981,"twenty":-43.849732,"median":-28.439666,"eighty":9.410143,"marketCap":4684813960},{"date":"2024-09-06","current":15.319151,"twenty":-43.849732,"median":-28.439666,"eighty":9.422608,"marketCap":4422991316},{"date":"2024-09-13","current":15.775418,"twenty":-43.849732,"median":-28.439666,"eighty":9.46156,"marketCap":4554725980},{"date":"2024-09-20","current":16.283014,"twenty":-43.849732,"median":-28.439666,"eighty":9.509862,"marketCap":4701280792},{"date":"2024-09-27","current":15.701275,"twenty":-43.849732,"median":-28.439666,"eighty":9.56787,"marketCap":4533319097},{"date":"2024-10-04","current":16.522554,"twenty":-43.849732,"median":-28.439666,"eighty":9.600231,"marketCap":4770441491},{"date":"2024-10-11","current":16.488334,"twenty":-43.849732,"median":-28.439666,"eighty":9.670346,"marketCap":4760561391},{"date":"2024-10-18","current":16.123321,"twenty":-43.849732,"median":-28.439666,"eighty":9.754483,"marketCap":4655173660},{"date":"2024-10-25","current":12.663801,"twenty":-43.849732,"median":-28.439666,"eighty":11.422026,"marketCap":4221427433},{"date":"2024-11-01","current":12.848249,"twenty":-43.849732,"median":-28.439666,"eighty":11.702607,"marketCap":4282912386},{"date":"2024-11-08","current":14.008329,"twenty":-43.849732,"median":-28.439666,"eighty":12.289298,"marketCap":4669620380},{"date":"2024-11-15","current":13.683118,"twenty":-43.849732,"median":-28.439666,"eighty":12.552615,"marketCap":4561212700},{"date":"2024-11-22","current":13.969498,"twenty":-43.849732,"median":-28.439666,"eighty":12.712777,"marketCap":4656676180},{"date":"2024-11-29","current":14.085991,"twenty":-43.849732,"median":-28.439666,"eighty":12.812597,"marketCap":4695508782},{"date":"2024-12-06","current":15.27034,"twenty":-43.849732,"median":-28.439666,"eighty":12.900671,"marketCap":5090306901},{"date":"2024-12-13","current":14.809221,"twenty":-43.849732,"median":-28.439666,"eighty":13.110355,"marketCap":4936594519},{"date":"2024-12-20","current":14.42091,"twenty":-43.849732,"median":-28.439666,"eighty":13.442537,"marketCap":4807152512},{"date":"2024-12-27","current":14.343247,"twenty":-43.849732,"median":-28.439666,"eighty":13.559902,"marketCap":4781264111},{"date":"2025-01-03","current":14.095699,"twenty":-43.849732,"median":-28.439666,"eighty":13.693488,"marketCap":4698744832},{"date":"2025-01-10","current":13.629725,"twenty":-43.863842,"median":-28.440211,"eighty":13.770488,"marketCap":4543414424},{"date":"2025-01-17","current":14.304416,"twenty":-43.863842,"median":-28.440211,"eighty":13.833589,"marketCap":4768319910},{"date":"2025-01-24","current":15.139285,"twenty":-43.863842,"median":-28.440211,"eighty":13.948176,"marketCap":5046620224},{"date":"2025-01-31","current":15.304318,"twenty":-43.863842,"median":-28.440211,"eighty":13.976354,"marketCap":5101633077},{"date":"2025-02-07","current":15.323733,"twenty":-43.863842,"median":-28.440211,"eighty":14.085991,"marketCap":5108105177},{"date":"2025-02-14","current":15.899471,"twenty":-43.863842,"median":-28.440211,"eighty":14.192777,"marketCap":5836218864},{"date":"2025-02-21","current":15.646958,"twenty":-43.863842,"median":-28.440211,"eighty":14.231608,"marketCap":5743528846},{"date":"2025-02-28","current":15.208382,"twenty":-43.863842,"median":-28.440211,"eighty":14.30927,"marketCap":5582540920},{"date":"2025-03-07","current":15.217242,"twenty":-43.873027,"median":-28.454574,"eighty":14.44615,"marketCap":5585793201},{"date":"2025-03-14","current":15.075481,"twenty":-43.873027,"median":-28.454574,"eighty":14.62089,"marketCap":5533756700},{"date":"2025-03-21","current":15.327994,"twenty":-43.873027,"median":-28.454574,"eighty":14.815514,"marketCap":5626446718},{"date":"2025-03-28","current":14.913262,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":5474211098},{"date":"2025-04-04","current":13.498725,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":4954976983},{"date":"2025-04-11","current":12.124603,"twenty":-43.863842,"median":-28.440211,"eighty":14.886883,"marketCap":4450578129},{"date":"2025-04-17","current":12.124603,"twenty":-43.863842,"median":-28.440211,"eighty":14.886883,"marketCap":4450578129},{"date":"2025-04-25","current":12.501813,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":4589040559},{"date":"2025-05-02","current":14.858162,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":5240562837},{"date":"2025-05-09","current":14.086734,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":4968475717},{"date":"2025-05-16","current":14.68985,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":5181198374},{"date":"2025-05-23","current":14.049332,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":4955283614},{"date":"2025-05-30","current":14.142838,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":4988263871},{"date":"2025-06-06","current":14.493487,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":5111939835},{"date":"2025-06-13","current":14.39063,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":5075661552},{"date":"2025-06-20","current":13.712709,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4836554689},{"date":"2025-06-27","current":13.478943,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4754104046},{"date":"2025-07-03","current":13.488294,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4757402072},{"date":"2025-07-11","current":14.24102,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":5022893141},{"date":"2025-07-18","current":13.726735,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4841501727},{"date":"2025-07-25","current":12.40362,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4374831091},{"date":"2025-08-01","current":12.549766,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4372915663},{"date":"2025-08-08","current":12.59951,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4390248851},{"date":"2025-08-15","current":13.388312,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4665103686},{"date":"2025-08-22","current":13.767316,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4797166069},{"date":"2025-08-29","current":13.705728,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4775705932},{"date":"2025-09-05","current":13.70099,"twenty":-43.891396,"median":-28.472159,"eighty":14.891062,"marketCap":4774055152},{"date":"2025-09-12","current":13.127747,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4574310798},{"date":"2025-09-19","current":13.525701,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4712976300},{"date":"2025-09-26","current":12.852969,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4478565570},{"date":"2025-10-03","current":14.809576,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":5160337623},{"date":"2025-10-10","current":14.866427,"twenty":-43.882212,"median":-28.468938,"eighty":14.901614,"marketCap":5180146981},{"date":"2025-10-17","current":14.591649,"twenty":-43.882212,"median":-28.468938,"eighty":14.926634,"marketCap":5084401753},{"date":"2025-10-24","current":14.231595,"twenty":-43.882212,"median":-28.468938,"eighty":14.926634,"marketCap":4958942489},{"date":"2025-10-31","current":15.019277,"twenty":-43.882212,"median":-28.43912,"eighty":15.006893,"marketCap":5088921627},{"date":"2025-11-07","current":15.438375,"twenty":-43.882212,"median":-28.345638,"eighty":15.018474,"marketCap":5230922685},{"date":"2025-11-14","current":15.111868,"twenty":-43.882212,"median":-28.24177,"eighty":15.075763,"marketCap":5120293954},{"date":"2025-11-21","current":13.737619,"twenty":-43.882212,"median":-28.181663,"eighty":15.075763,"marketCap":4654662578},{"date":"2025-11-28","current":14.414997,"twenty":-43.882212,"median":-28.038026,"eighty":15.075763,"marketCap":4884175916},{"date":"2025-12-05","current":14.278547,"twenty":-43.882212,"median":-27.899005,"eighty":15.075763,"marketCap":4837943013},{"date":"2025-12-12","current":14.215195,"twenty":-43.674768,"median":-27.712042,"eighty":15.075763,"marketCap":4816477737},{"date":"2025-12-19","current":13.552437,"twenty":-43.352661,"median":-27.649721,"eighty":15.075763,"marketCap":4591917925},{"date":"2025-12-26","current":13.898436,"twenty":-43.181925,"median":-27.578386,"eighty":15.075763,"marketCap":4709151356},{"date":"2026-01-02","current":13.635282,"twenty":-42.896368,"median":-27.514693,"eighty":15.075763,"marketCap":4619987901},{"date":"2026-01-09","current":14.424744,"twenty":-42.786484,"median":-27.36293,"eighty":15.075763,"marketCap":4887478266},{"date":"2026-01-16","current":15.214206,"twenty":-42.614728,"median":-26.975109,"eighty":15.077555,"marketCap":5154968630},{"date":"2026-01-23","current":16.544596,"twenty":-42.460696,"median":-26.774017,"eighty":15.108565,"marketCap":5605739430},{"date":"2026-01-30","current":16.997806,"twenty":-42.298396,"median":9.072035,"eighty":15.139285,"marketCap":5759298713},{"date":"2026-02-06","current":16.349667,"twenty":-42.121898,"median":9.212264,"eighty":15.161285,"marketCap":5539692426},{"date":"2026-02-13","current":16.222964,"twenty":-41.959732,"median":9.350441,"eighty":15.201872,"marketCap":5496761874},{"date":"2026-02-20","current":15.594318,"twenty":-41.959732,"median":9.370022,"eighty":15.220786,"marketCap":5283760288},{"date":"2026-02-27","current":21.19121,"twenty":-41.959732,"median":9.407027,"eighty":15.261496,"marketCap":5121152471},{"date":"2026-03-06","current":19.549977,"twenty":-41.959732,"median":9.422608,"eighty":15.297588,"marketCap":4724525628},{"date":"2026-03-13","current":19.060366,"twenty":-41.959732,"median":9.46156,"eighty":15.319151,"marketCap":4606204175},{"date":"2026-03-20","current":19.584457,"twenty":-41.959732,"median":9.512199,"eighty":15.336854,"marketCap":4732858125},{"date":"2026-03-27","current":20.632639,"twenty":-41.959732,"median":9.570627,"eighty":15.412902,"marketCap":4986166025},{"date":"2026-04-02","current":24.112643,"twenty":-41.959732,"median":9.593999,"eighty":15.466036,"marketCap":5827157765},{"date":"2026-04-10","current":24.02321,"twenty":-41.959732,"median":9.664113,"eighty":15.524453,"marketCap":5805544912},{"date":"2026-04-17","current":23.228627,"twenty":-41.959732,"median":9.742018,"eighty":15.606447,"marketCap":5613523023},{"date":"2026-04-24","current":23.32838,"twenty":-41.959732,"median":11.418222,"eighty":15.661134,"marketCap":5637629667},{"date":"2026-05-01","current":23.19079,"twenty":-41.959732,"median":11.622713,"eighty":15.730243,"marketCap":5604379123},{"date":"2026-05-08","current":38.634911,"twenty":-41.959732,"median":11.940489,"eighty":15.814201,"marketCap":5900323567},{"date":"2026-05-15","current":41.8654,"twenty":-41.959732,"median":12.174,"eighty":15.879905,"marketCap":6393683956},{"date":"2026-05-22","current":40.326552,"twenty":-41.959732,"median":12.331299,"eighty":15.906771,"marketCap":6158671068},{"date":"2026-05-29","current":43.589783,"twenty":-41.964268,"median":12.423564,"eighty":15.957458,"marketCap":6657031731},{"date":"2026-06-05","current":47.344136,"twenty":-41.959732,"median":12.501813,"eighty":16.013817,"marketCap":7230396507},{"date":"2026-06-12","current":49.024864,"twenty":-41.898367,"median":12.572144,"eighty":16.034853,"marketCap":7487077250},{"date":"2026-06-18","current":48.577398,"twenty":-41.824976,"median":12.578191,"eighty":16.107352,"marketCap":7418740169},{"date":"2026-06-26","current":57.657693,"twenty":-41.817921,"median":12.645689,"eighty":16.158784,"marketCap":8805482883},{"date":"2026-07-02","current":56.446259,"twenty":-41.803329,"median":12.68891,"eighty":16.20592,"marketCap":8620472738},{"date":"2026-07-10","current":58.694506,"twenty":-41.535725,"median":12.773878,"eighty":16.314234,"marketCap":8963824900},{"date":"2026-07-17","current":56.686363,"twenty":-41.52535,"median":12.829717,"eighty":16.483549,"marketCap":8657141415},{"date":"2026-07-24","current":57.810486,"twenty":-41.508406,"median":12.912967,"eighty":16.53282,"marketCap":8828817496},{"date":"2026-07-31","current":126.933087,"twenty":-41.435384,"median":12.976145,"eighty":16.764866,"marketCap":8393196498},{"date":"2026-08-07","current":122.721435,"twenty":-41.179453,"median":13.089846,"eighty":17.012426,"marketCap":8114709466},{"date":"2026-08-14","current":125.461546,"twenty":-40.97486,"median":13.175122,"eighty":18.458256,"marketCap":8295893800},{"date":"2026-08-21","current":121.833436,"twenty":-40.812598,"median":13.242761,"eighty":18.732957,"marketCap":8055992321},{"date":"2026-08-24","current":122.61995,"twenty":-40.804002,"median":13.319617,"eighty":18.760477,"marketCap":8107998935}],"updateTime":1787700373364},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALKS\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2637380893","title":"Alkermes presents real-world study comparing Lybalvi versus olanzapine adherence, relapse proxies","url":"https://stock-news.laohu8.com/highlight/detail?id=2637380893","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637380893?lang=en_us&edition=fundamental","pubTime":"2026-05-21 19:01","pubTimestamp":1779361264,"startTime":"0","endTime":"0","summary":"Alkermes flagged new real-world studies on LYBALVI and ARISTADA, with results already presented at spring 2026 psychiatry and health-economics conferences.Real-world analyses comparing LYBALVI with olanzapine pointed to stronger treatment adherence and persistence, with fewer relapse-related acute-care events such as hospitalizations or emergency-room visits.A separate study in young adults showed a reduction in relapse proxies in the year following LYBALVI initiation versus the prior year.The disclosures add post-launch evidence aimed at supporting LYBALVI’s positioning in schizophrenia and bipolar I disorder, with an emphasis on outcomes tied to utilization and continuity of care.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alkerm","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL7dfDDz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637878129","title":"Alkermes shareholders approve 2018 stock plan share increase by 5.9 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2637878129","media":"Reuters","labels":["executive","shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637878129?lang=en_us&edition=fundamental","pubTime":"2026-05-21 04:11","pubTimestamp":1779307908,"startTime":"0","endTime":"0","summary":"Alkermes held its annual general meeting on May 20, 2026.Shareholders backed amendments to the 2018 Stock Option and Incentive Plan, increasing the number of ordinary shares authorized for issuance under the plan by 5,900,000.Shareholders renewed the board’s authority to allot and issue shares under Irish law.Shareholders also renewed the board’s authority to disapply statutory pre-emption rights under Irish law.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alkermes plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 20, 2026, and is solely responsible for the information contained ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nNDL91yff6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635039670","title":"Alkermes Advances Phase 3 Narcolepsy Study With ALKS 2680, Adding a New Catalyst to Its Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2635039670","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635039670?lang=en_us&edition=fundamental","pubTime":"2026-05-16 00:32","pubTimestamp":1778862770,"startTime":"0","endTime":"0","summary":"Alkermes plc ($ALKS) announced an update on their ongoing clinical study. The Brilliance NT1 Study 304 is a phase 3 trial run by Alkermes, Inc. to ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alkermes-advances-phase-3-narcolepsy-study-with-alks-2680-adding-a-new-catalyst-to-its-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alkermes-advances-phase-3-narcolepsy-study-with-alks-2680-adding-a-new-catalyst-to-its-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635891217","title":"Alkermes Is Maintained at Outperform by Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2635891217","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635891217?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:26","pubTimestamp":1778671560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALKS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 13, 2026 07:26 ET (11:26 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635242235","title":"Sector Update: Healthcare Stocks Advance Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2635242235","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635242235?lang=en_us&edition=fundamental","pubTime":"2026-05-13 03:58","pubTimestamp":1778615885,"startTime":"0","endTime":"0","summary":"Healthcare stocks advanced late Tuesday afternoon, with the NYSE Healthcare Index and the State Street Healthcare Select Sector SPDR ETF (XLV) each rising about 2%.The iShares Biotechnology ETF (IBB) ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","IE00BZ1G4Q59.USD","XBI","LU0154236417.USD","BK4121","SNDA","BK4137","IBB","LU0128526141.USD","BK4585","LU1093756168.USD","BK7104","NVOH","BK4567","BK4185","LU1093756325.SGD","LU0348744763.USD","LABU","NVOX","LU0106261612.USD","LU0345774391.USD","IE00B64QTZ34.USD","BK4523","WST","BK4599","IE00BFXG0V08.USD","BK4557","XLV","BK4139","IE00BYQQ9H92.USD","BK4504","IE00BKVL7J92.USD","LU0012050646.USD","BK7016","LU0029874061.USD","NVO","BK4596","RDY","LU0345774631.USD","ALKS","BK4581","BK4007","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635324406","title":"Alkermes' (NASDAQ:ALKS) Conservative Accounting Might Explain Soft Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2635324406","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635324406?lang=en_us&edition=fundamental","pubTime":"2026-05-13 02:25","pubTimestamp":1778610326,"startTime":"0","endTime":"0","summary":"Soft earnings didn't appear to concern Alkermes plc's ( NASDAQ:ALKS ) shareholders over the last week. We did some...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alks/alkermes/news/alkermes-nasdaqalks-conservative-accounting-might-explain-so","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alks/alkermes/news/alkermes-nasdaqalks-conservative-accounting-might-explain-so","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":[".IXIC","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107990839","title":"Stock Track | Alkermes Soars 6.37% Intraday on Positive Phase 3 Trial Results for Lumryz in Idiopathic Hypersomnia","url":"https://stock-news.laohu8.com/highlight/detail?id=1107990839","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107990839?lang=en_us&edition=fundamental","pubTime":"2026-05-13 02:19","pubTimestamp":1778609983,"startTime":"0","endTime":"0","summary":"Alkermes PLC's stock surged 6.37% during Tuesday's intraday trading session following the announcement of successful late-stage clinical trial results for its investigational drug.The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634214157","title":"Alkermes Phase 3 Trial Meets Primary Endpoint for Hypersomnia Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2634214157","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634214157?lang=en_us&edition=fundamental","pubTime":"2026-05-12 21:00","pubTimestamp":1778590808,"startTime":"0","endTime":"0","summary":"Alkermes  said Tuesday a late-stage trial evaluating its investigational Lumryz oral suspension in adults with idiopathic hypersomnia, a rare condition in which patients require excessive sleep, met all primary and key secondary endpoints.The medication demonstrated statistically significant reductions in excessive daytime sleepiness alongside improvements in patient-reported disease severity when compared to a placebo, the company said.Participants who were switched to a placebo during the withdrawal phase experienced significant symptom worsening compared to subjects who continued treatment, Alkermes said.The company plans to submit a supplemental new drug application to the US Food and Drug Administration by the end of the year, it said.Shares of the company were up 1.3% in Tuesday premarket activity.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634211199","title":"Analysts Conflicted on These Healthcare Names: Cronos Group (CRON), Savara (SVRA) and Alkermes (ALKS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634211199","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634211199?lang=en_us&edition=fundamental","pubTime":"2026-05-12 20:30","pubTimestamp":1778589035,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Cronos Group (CRON), Savara (SVRA) and Alkermes (ALKS). Cronos Gr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-cronos-group-cron-savara-svra-and-alkermes-alks-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-cronos-group-cron-savara-svra-and-alkermes-alks-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4581","BK4585","ALKS","BK4137","CRON","LU0029874061.USD","LU0128526141.USD","SVRA","XLV","BK4007","BK4139","XBI","BK4588","BK4557","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634442218","title":"BRIEF-Alkermes Announces Positive Topline Results From Revitalyz Phase 3 Study Evaluating Lumryz","url":"https://stock-news.laohu8.com/highlight/detail?id=2634442218","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634442218?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:02","pubTimestamp":1778583730,"startTime":"0","endTime":"0","summary":"BRIEF-Alkermes Announces Positive Topline Results From Revitalyz Phase 3 Study Evaluating LumryzMay 12 (Reuters) - Alkermes Plc ALKS.O:ALKERMES ANNOUNCES POSITIVE TOPLINE RESULTS FROM REVITALYZ PHASE ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nTUA32BKGT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634218427","title":"Alkermes says Phase 3 REVITALYZ trial shows LUMRYZ improves idiopathic hypersomnia sleepiness","url":"https://stock-news.laohu8.com/highlight/detail?id=2634218427","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634218427?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:01","pubTimestamp":1778583712,"startTime":"0","endTime":"0","summary":"Alkermes reported positive topline results from REVITALYZ, a Phase 3 study of once-nightly LUMRYZ in adults with idiopathic hypersomnia.Trial met primary endpoint, showing meaningful improvement versus placebo in daytime sleepiness and patient-reported disease severity, with safety consistent with established LUMRYZ profile.Detailed results will be presented at a future medical meeting.Company plans to file a supplemental New Drug Application with FDA by end of 2026, though it cannot market LUMRYZ for idiopathic hypersomnia before March 1, 2028 under a prior settlement.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDLbbwPvq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALKS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634964218","title":"Alkermes Plc - May Not Market Lumryz for Ih Before March 1, 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2634964218","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634964218?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:00","pubTimestamp":1778583601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nTUA32BKGT:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALKS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634321890","title":"Alkermes Plc - Lumryz Meets All Primary and Key Secondary Endpoints in Revitalyz Phase 3 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2634321890","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634321890?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:00","pubTimestamp":1778583601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nTUA32BKGT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALKS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634218642","title":"Alkermes Plc - Lumryz Safety Profile in Revitalyz Study Consistent With Known Safety Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2634218642","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634218642?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:00","pubTimestamp":1778583601,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nTUA32BKGT:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634218609","title":"Alkermes Announces Positive Topline Results From Revitalyz℠ Phase 3 Study Evaluating Lumryz® (Sodium Oxybate) Extended-Release in Adults With Idiopathic Hypersomnia","url":"https://stock-news.laohu8.com/highlight/detail?id=2634218609","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634218609?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:00","pubTimestamp":1778583601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nTUA32BKGT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALKS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634314284","title":"Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY), Maravai Lifesciences Holdings (MRVI) and Alkermes (ALKS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634314284","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634314284?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:50","pubTimestamp":1778503813,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Harmony Biosciences Holdings (HRMY), Maravai Lifes...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-harmony-biosciences-holdings-hrmy-maravai-lifesciences-holdings-mrvi-and-alkermes-alks-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-harmony-biosciences-holdings-hrmy-maravai-lifesciences-holdings-mrvi-and-alkermes-alks-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4137","LU0128526141.USD","BK4007","ALKS","BK4588","LABU","BK4121","LU0029874061.USD","HRMY","HCSG","BK4581","XBI","XLV","MRVI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634475355","title":"Analysts Offer Insights on Healthcare Companies: Medline (MDLN), Aclaris Therapeutics (ACRS) and Alkermes (ALKS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634475355","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634475355?lang=en_us&edition=fundamental","pubTime":"2026-05-11 10:41","pubTimestamp":1778467285,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Medline (MDLN), Aclaris Therapeutics (ACRS) and Alkermes (ALKS). ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-medline-mdln-aclaris-therapeutics-acrs-and-alkermes-alks-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-medline-mdln-aclaris-therapeutics-acrs-and-alkermes-alks-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","HCSG","XLV","XBI","BK4139","LU0029874061.USD","LABU","BK4007","BK4137","BK4588","MDLN","BK4198","ACRS","BK4585","LU0128526141.USD","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633709193","title":"Alkermes price target raised to $50 from $45 at Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2633709193","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633709193?lang=en_us&edition=fundamental","pubTime":"2026-05-07 11:49","pubTimestamp":1778125763,"startTime":"0","endTime":"0","summary":"Needham raised the firm’s price target on Alkermes (ALKS) to $50 from $45 and keeps a Buy rating on the shares after its Q1 results. The stock is u...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alkermes-price-target-raised-to-50-from-45-at-needham-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alkermes-price-target-raised-to-50-from-45-at-needham-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALKS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633153690","title":"Alkermes Analysts Increase Their Forecasts Following Strong Q1 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2633153690","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633153690?lang=en_us&edition=fundamental","pubTime":"2026-05-07 01:54","pubTimestamp":1778090050,"startTime":"0","endTime":"0","summary":"Alkermes reports positive Q1 results, beating expectations. Raises EPS guidance and maintains sales guidance. Analysts raise price targets.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/05/52336630/alkermes-analysts-increase-their-forecasts-following-strong-q1-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633733130","title":"Alkermes' Q1 Revenue Beat Highlights 'Underappreciated' Core Business, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2633733130","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633733130?lang=en_us&edition=fundamental","pubTime":"2026-05-07 00:37","pubTimestamp":1778085459,"startTime":"0","endTime":"0","summary":"Alkermes'  better-than-expected Q1 revenue highlights the \"underappreciated nature\" of the company's core business, analysts at RBC Capital Markets said in a Tuesday note.Management remains confident in the company's competitive position and multiple catalysts can serve as value inflection points, including phase 2 and phase 3 three idiopathic hypersomnia data and early stage ADHD data, the RBC analysts said.Q1 royalty revenue came in better than expected, helped by a strong quarter for Vumerity. RBC now expects $1.81 billion in 2026 revenue and said if the strength continues in Q2, the company could point investors to the higher end of its guidance range, according to the note.RBC said it is looking forward to alixorexton data in idiopathic hypersomnia in H2, which could add another $1 billion in 2035 sales, for a total opportunity of more than $3 billion.While revenue is strong, the company is maintaining its product-by-product and total revenue guidance of $1.73 billion to $1.84 bil","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":6,"totalSize":176,"code":"91000000","status":"200"}]}}